Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)

NACompletedINTERVENTIONAL
Enrollment

921

Participants

Timeline

Start Date

August 11, 2015

Primary Completion Date

July 3, 2019

Study Completion Date

June 5, 2020

Conditions
Gestational DiabetesPregnancyGlucose Intolerance
Interventions
DIAGNOSTIC_TEST

Gestational diabetes screening with fasting 3 hour 100 gm

Participants receive fasting 3 hour 100 gm oral glucose tolerance test

DIAGNOSTIC_TEST

Gestational diabetes screening with fasting 2 hour 75g

Participants receive fasting 2 hour 75 gm oral glucose tolerance test

Trial Locations (1)

15213

UPMC- Magee Womens Hospital, Pittsburgh

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Esa M Davis, MD MPH FAAFP

OTHER

NCT02309138 - Comparison of Two Screening Strategies for Gestational Diabetes (GDM2) | Biotech Hunter | Biotech Hunter